Clorox faces weak Q1 results from ERP issues and sluggish consumer demand. Click for insights on growth outlook, valuation, ...
StockStory.org on MSN
CLX Q3 Deep Dive: ERP Launch, Promotional Pressures, and Innovation Drive Outlook
Consumer products giant Clorox (NYSE:CLX) in Q3 CY2025, but sales fell by 18.9% year on year to $1.43 billion. Its non-GAAP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback